Redefining Lung Cancer Together: Biomarker testing in lung cancer

Did you know that biomarker testing can help guide lung cancer treatment? Lorraine and Mark discuss her first-hand experience of testing and shed light on the need for people to know why, how and when to talk to their doctor about it.

In this Redefining Lung Cancer Together podcast episode, Emilie Prazakova – Senior Patient Partnership Leader at Roche – sits down with Lorraine Tyler, an advocate and woman living with lung cancer, and Mark Brooke, CEO of Lung Foundation Australia, to discuss the critical importance of biomarker testing in lung cancer.

Lorraine and Mark have a touching discussion, sharing personal perspectives about the positive impact that early biomarker testing can have on the lives of people with lung cancer, and advice for how people can talk to their doctor and find out more about it.

More stories

See all stories

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeCovid-19Pharma solutionsRoche careersMedia libraryAnnual Report 2023Privacy policyLegal statement